2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Hypothalamic Neoplasms: new trials by email Literature Review of Hypothalamic Neoplasms trials Research Report on Hypothalamic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas TBR-760, Placebo - Non-Functional Pituitary Adenoma, Pituitary Tumor, Nonfunctioning | Phase 2 | Unknown | Tiburio Therapeutics | 150 | 2020-05-01 | 2020-04-06 |
| The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas Radiotherapy plus temozolomide, Radiotherapy plus placebo - Pituitary Adenomas | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 150 | 2020-02-10 | 2020-01-28 |
Brain Diseases (2) · Brain Neoplasms (2) · Central Nervous System Diseases (2) · Central Nervous System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Hypothalamic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Pituitary Diseases (2) · Supratentorial Neoplasms (2)
Radiotherapy (1) · TBR-760 (1) · Temozolomide (1)
Peking Union Medical College Hospital (1) · Tiburio Therapeutics (1)